Skip to main content
logo
Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.450
+0.230 (10.36%)
Sep 14, 2026, 4:00 PM EDT - Market closed

Serina Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
622047---
Market Cap Growth
16.97%-56.65%----
Enterprise Value
432055---
Last Close Price
2.221.915.01---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-156.93840.25---
PB Ratio
3.01-551.3692.63---
P/TBV Ratio
3.25-73.41---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-153.39990.71---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.20-89.810.530.90-0.771.19
Net Debt / Equity Ratio
-1.03-7.22-6.70-0.95-0.55-2.73
Net Debt / EBITDA Ratio
0.75-0.010.222.73-0.580.57
Net Debt / FCF Ratio
0.91-0.010.201.32-0.610.39
Asset Turnover
-0.020.010.640.44-
Quick Ratio
6.120.861.555.391.223.53
Current Ratio
6.651.712.405.391.253.58
Return on Equity (ROE)
-207.94%-8159.24%-485.36%594.25%--
Return on Assets (ROA)
-92.30%-219.58%-124.04%-19.46%-105.01%-
Return on Capital Employed (ROCE)
-116.40%-709.00%-357.30%-20.30%-540.10%-110.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-39.25%-94.03%-23.68%---
FCF Yield
-34.78%-88.30%-36.47%---
Buyback Yield / Dilution
-30.50%-38.47%-0.11%-242.70%-0.01%-
SEC Filings: 10-K · 10-Q